| Summary of liabilities measured at fair value on a recurring basis |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities Measured at Fair Value on a Recurring Basis at | | | June 30, 2026 | | | Quoted Prices in | | Significant | | | | | | | | | Active Markets | | Other | | Significant | | | | | | for Identical | | Observable | | Unobservable | | Balance at | | | Assets | | Inputs | | Inputs | | June 30, | | | (Level 1) | | (Level 2) | | (Level 3) | | 2026 | Liabilities | | | | | | | | | | | | | Warrants (Note 17) | | $ | — | | $ | — | | $ | 14,965 | | $ | 14,965 | Contingent consideration (Note 7) | | | — | | | — | | | 2,809 | | | 2,809 | Total liabilities | | $ | — | | $ | — | | $ | 17,774 | | $ | 17,774 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities Measured at Fair Value on a Recurring Basis at | | | December 31, 2025 | | | Quoted Prices in | | Significant | | | | | | | | | Active Markets | | Other | | Significant | | | | | | for Identical | | Observable | | Unobservable | | Balance at | | | Assets | | Inputs | | Inputs | | December 31, | | | (Level 1) | | (Level 2) | | (Level 3) | | 2025 | Liabilities | | | | | | | | | | | | | Warrants (Note 17) | | $ | — | | $ | — | | $ | 5,624 | | $ | 5,624 | Contingent consideration (Note 7) | | | — | | | — | | | 1,811 | | | 1,811 | Total Liabilities | | $ | — | | $ | — | | $ | 7,435 | | $ | 7,435 |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities Measured at Fair Value on a Recurring Basis at | | | December 31, 2025 | | | Quoted Prices in | | | | | | | | | | | | Active Markets | | Significant Other | | Significant | | | | | | for Identical | | Observable | | Unobservable | | Balance at | | | Assets | | Inputs | | Inputs | | December 31, | | | (Level 1) | | (Level 2) | | (Level 3) | | 2025 | Liabilities | | | | | | | | | | | | | Warrants (Note 17) | | $ | — | | $ | — | | $ | 5,624 | | $ | 5,624 | Contingent consideration (Note 7) | | | — | | | — | | | 748 | | | 748 | Derivative – conversion feature embedded in convertible debt (Note 17) | | | — | | | — | | | — | | | — | Total liabilities | | $ | — | | $ | — | | $ | 6,372 | | $ | 6,372 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | Liabilities Measured at Fair Value on a Recurring Basis at | | | December 31, 2024 | | | Quoted Prices in | | | | | | | | | | | | Active Markets | | Significant Other | | Significant | | | | | | for Identical | | Observable | | Unobservable | | Balance at | | | Assets | | Inputs | | Inputs | | December 31, | | | (Level 1) | | (Level 2) | | (Level 3) | | 2024 | Liabilities | | | | | | | | | | | | | Warrants (Note 17) | | $ | — | | $ | — | | $ | 6,264 | | $ | 6,264 | Contingent consideration (Note 7) | | | — | | | — | | | 811 | | | 811 | Derivative - conversion feature embedded in convertible debt
(Note 17) | | | — | | | — | | | 393 | | | 393 | Total Liabilities | | $ | — | | $ | — | | $ | 7,468 | | $ | 7,468 |
|
| Summary of derivative liabilities, including conversion feature embedded in convertible debt and warrants |
| | | | | | | | | | | | | | | | Warrant and Derivative | | | Liability | | | June 30, | | December 31, | | | 2026 | | 2025 | Balance | | $ | 5,624 | | $ | 6,657 | Purchases, issuances, sales, and settlements: | | | | | | | Derivative – conversion feature embedded in convertible debt (Note 17) | | | — | | | (393) | Warrants exercised | | | — | | | (104) | Unrealized (gains) losses included in earnings related to investments still held as of reporting date | | | 9,341 | | | (536) | Balance | | $ | 14,965 | | $ | 5,624 |
|
| | | | | | | | | | | | | | | | Warrant and Derivative | | | Liability | | | 2025 | | 2024 | Balance | | $ | 6,657 | | $ | 6,816 | Purchases, issuances, sales, and settlements: | | | | | | | Derivative – conversion feature embedded in convertible debt (Note 17) | | | (393) | | | 393 | Warrants exercised | | | (104) | | | (918) | Unrealized (gains) losses included in earnings related to investments still held as of reporting date | | | (536) | | | 366 | Balance | | $ | 5,624 | | $ | 6,657 |
|